1000 Pharmaceuticals & Biotechnology

Gitte Pedersen: Genomic Expression

“The unpleasant truth is that only one out of four cancer treatments prolong life. To help rectify this, Genomic Expression finds the best drug for the patient and the best patient for the drug by sequencing RNA.”

Business Woman + Terminator

Growing up below the poverty line, Melissa Mowbray-D’Arbela, the founder of Filligent Technologies, learned to be resourceful at an early age.